This list is an analysis based on recent market events. It's not an investment recommendation.
About
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
The current price of BLLN.BOATS is $105.89 USD — it has increased by +1.21% in the past 24 hours. Watch Billiontoone stock price performance more closely on the chart.
What is Billiontoone stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Billiontoone stocks are traded under the ticker BLLN.BOATS.
What is Billiontoone market cap?▼
Today Billiontoone has the market capitalization of 5B
When is the next Billiontoone earnings date?▼
Billiontoone is going to release the next earnings report on December 15, 2026.
What were Billiontoone earnings last quarter?▼
BLLN.BOATS earnings for the last quarter are 0.15 USD per share, whereas the estimation was 0.18 USD resulting in a -18.15% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Billiontoone revenue for the last year?▼
Billiontoone revenue for the last year amounts to 305.11M USD.
What is Billiontoone net income for the last year?▼
BLLN.BOATS net income for the last year is 2.92M USD.